Washington, D.C. 20515
Dear Congressman Schrader and Congressman Kinzinger:
On behalf of the millions of patients, consumers, providers, communities of color, and taxpayers our organizations represent, we write to thank you for your leadership in introducing the BIOSIM Act (H.R. 2815). Biosimilar medicines hold enormous potential to lower the cost of prescription drugs but face significant barriers to adoption. Congressional action on innovative solutions, like the BIOSIM Act, is critical to reducing costs and improving patient access to biosimilars in the U.S.
The Food and Drug Administration (FDA) has approved 29 biosimilar medicines since 2015.i Patients with cancer, chronic kidney disease, rheumatoid arthritis and other conditions are benefitting from access to biosimilars. According to a recent analysis, women, seniors, and low-income individuals are expected to benefit most from increased access to biosimilars as they are predominantly impacted by the conditions currently tr
Heart Valve Disease Awareness Day Campaign Celebrates Fifth Anniversary with Focus on Health Disparities
Advocates Continue to Drive Forward Heart Valve Disease Awareness, While Highlighting the Inequities in Risk Factors, Diagnosis, and Treatment Faced by Black Americans
News provided by
Share this article
Share this article
WASHINGTON, Feb. 16, 2021 /PRNewswire/ On Monday, February 22, more than 90 national organizations and thousands of patient advocates will recognize the fifth anniversary of the annual HVD Awareness Day ( Valve Disease Day ) and the importance of addressing the disproportionate impact heart valve disease (HVD) has on America s Black communities. Valve Disease Day, an awareness day officially acknowledged by the U.S. Department of Health and Human Services, was established in 2017 by the Alliance for Aging Research ( Alliance ) to spotlight the importance of detecting and treating HVD. Many Valve Disease Day awareness efforts this year are focused on hi
×
Thanks for visiting HeraldMailMedia.com. You re entitled to limited access of articles every 30 days. If you enjoy our site and want full access, we ask you to purchase an affordable subscription.
×
Thank you for reading! On your next view you will be asked to log in to your subscriber account or create an account and subscribepurchase a subscription to continue reading.
×
Thank you for reading HeraldMailMedia.com free articles on our site. You can come back at the end of your 30-day period for more free articles, or you can purchase a subscription and continue to enjoy valuable local news and information. If you need help, please contact our office at 301-733-5131.